Disclaimer - Please note that the insurance accepted list may not be complete. Prior to scheduling an appointment, please contact the doctors' office to verify their participation in your plan.
| Subspecialty | Pulmonary Disease |
|---|---|
| Clinical Interests | Interstitial Lung Disease |
| Internal Medicine | |
| Lung Cancer | |
| Pulmonary Disease/COPD | |
| Languages | English |
| Spanish | |
| Gender | Male |
| alvin.teirstein@mssm.edu | |
| Education and Training | MD, S.U.N.Y., Downstate Medical Center |
| Residency, Rotating, Mount Sinai Hospital | |
| Residency, Internal Medicine, Mount Sinai Hospital | |
| Residency, Internal Medicine, Mount Sinai Hospital | |
| Fellowship, Cardiopulmonary Lab, Mount Sinai Hospital |
| Education and Training | MD, S.U.N.Y., Downstate Medical Center |
|---|---|
| Residency, Rotating, Mount Sinai Hospital | |
| Residency, Internal Medicine, Mount Sinai Hospital | |
| Residency, Internal Medicine, Mount Sinai Hospital | |
| Fellowship, Cardiopulmonary Lab, Mount Sinai Hospital | |
| Board Certification | Pulmonary Disease |
| Subspecialty | Pulmonary Disease |
|---|---|
| Clinical Interests | Interstitial Lung Disease |
| Internal Medicine | |
| Lung Cancer | |
| Pulmonary Disease/COPD | |
| Languages | English |
| Spanish | |
| Board Certification | Pulmonary Disease |
Diffuse lung diseases which have focused both on the role of the Kveim reagent in the diagnosis of sarcoidosis and its use as the only in vivo model of sarcoid granuloma formation
Our laboratories have examined the immunol ogical cascade initiated by the Kveim reagent. In collaboration with national and international groups we are presently investigating the specific immunological response at the cellular and molecular level. The Mt. Sinai sarcoidosis laboratories have vig orously pursued the etiologic agent of sarcoidosis. Using the Kveim reagent and sarcoidal tissues we are attempting to identify a specific etiologic agent and recapitulate the disease in an appropriate animal model. We have a long history of the study of other "interstitial" lung disease including pulmonary asbestosis, idiopathic pulmonary fibrosis and pulmonary disease secondary to connective tissue diseases such as scleroderma and rheumatoid arthritis
The Mount Sinai Medical Center is home to an extensive array of top-notch research centers and laboratories, where scientists and researchers work to translate the rapid advances in basic science into the innovative patient care for which we are known.
Participating in Mount Sinai’s clinical trials allows you to take advantage of innovative treatments as we work together to advance the future of medicine.
